Cancer immunotherapies
The company researches, develops, and commercializes immunotherapies to treat cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
Coherus is a commercial-stage biopharmaceutical company focused on researching, developing, and commercializing immunotherapies to treat cancer.
The company commercializes a portfolio of FDA-approved therapeutics.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company researches, develops, and commercializes immunotherapies to treat cancer.
Source: LinkedIn company description · Retrieved October 13, 2026
The company has a diversified portfolio of FDA-approved biosimilar products.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 15, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.